Detalhe da pesquisa
1.
PKCß Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling.
Cancers (Basel)
; 14(23)2022 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36497487
2.
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.
Leukemia
; 34(7): 1975, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005922
3.
CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy.
Leukemia
; 34(6): 1613-1625, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31896780
4.
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia.
Sci Rep
; 6: 25476, 2016 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27157927